This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Laly Havern, PharmD, MS, BCACP
Advertisement
Articles by Laly Havern, PharmD, MS, BCACP
These agents are likely to become the mainstay of cancer treatment in the very near future.
Advertisement
Latest Updated Articles
Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer HospitalizationsPublished: February 7th 2023 | Updated:
Evaluation of a Pharmacy-Delivered Oncofertility InterventionPublished: June 11th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
4
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
5
